NEUROPROTECTIVE EFFECT OF 7,3´-DIHYDROXYFLAVONE AGAINST PACLITAXEL-INDUCED NEUROTOXICITY IN SH-SY5Y NEUROBLASTOMA CELL LINE: AN IN VITRO MODEL DOI Open Access

KEERTHANA VIJAYARAJAN,

KAVITHA RAMASAMY,

Kranthi Karunai Kadal

и другие.

Asian Journal of Pharmaceutical and Clinical Research, Год журнала: 2025, Номер unknown, С. 130 - 135

Опубликована: Март 7, 2025

Objectives: Paclitaxel (PT) induced peripheral neuropathy is associated with the neurotoxic effects of this chemotherapeutic drug. As a result, need for natural substances that can mitigate neural toxicity rising. This study investigated Neuroprotective 7,3´-dihydroxyflavone (7,3´-DHF) on PT-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Methods: The cells were exposed to 1 μM concentration PT, and protective various concentrations 7,3´-DHF evaluated. reactive oxygen species (ROS) level was measured using confocal fluorescence microscopy. proinflammatory cytokines, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) determined by enzyme-linked immunosorbent assay. Results: Treatment PT significantly reduced cell viability 19±4.8%. However, treatment PT-exposed elevated dose-dependent manner, reaching 55.34±3.8% 83.93±4.1% at 75 μg/mL 100 μg/mL, respectively. exposure ROS levels cells, but presence against toxicity. In addition, lowered increased IL-6 TNF-α exposure. Conclusion: effectively preserved under effect mediated through suppression production attenuation cytokine release, highlighting its potential as neuroprotective agent.

Язык: Английский

Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer DOI Creative Commons
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz

и другие.

Chemistry & Biodiversity, Год журнала: 2025, Номер unknown

Опубликована: Янв. 7, 2025

ABSTRACT Hinokitiol (HK), a monoterpenoid that naturally occurs in plants belonging to the Cupressaceae family, possesses important biological activities, including an anticancer effect. This review summarizes its potential and draws possible molecular interventions. In addition, it evaluates biopharmaceutical, toxicological properties, clinical application of HK establish viability for future advancement as dependable medication. The assessment is based on most recent information available from various databases. Findings demonstrate substantial therapeutic advantages against diverse types cancer (colon, cervical, breast, bone, endometrial, liver, prostate, oral, skin) through mechanisms. induces oxidative stress, cytotoxicity, apoptosis, cell‐cycle arrest at G S phases, autophagy modulation phosphatidylinositol 3‐kinase (PI3K)/Akt/mammalian target rapamycin (mTOR), p38/ERK/MAPK, nuclear factor kappa B, c‐Jun N‐terminal kinase signaling pathways. Furthermore, this compound exhibits good oral bioavailability with excellent plasma clearance. Clinical uses without any significant negative effects. A thorough study pertinent data suggests may serve viable candidate developing novel therapies. Consequently, more extensive studies are necessary evaluate treatment efficacy, safety, long‐term hazards.

Язык: Английский

Процитировано

0

Revealing rutaecarpine’s promise: A pathway to parkinson’s disease relief through PPAR modulation DOI Creative Commons
Yeying Wang, Bin Liao, Xuesong Shan

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 147, С. 114076 - 114076

Опубликована: Янв. 13, 2025

Язык: Английский

Процитировано

0

Hinokitiol ameliorates MASH in mice by therapeutic targeting of hepatic Nrf2 and inhibiting hepatocyte ferroptosis DOI

Xunzhe Yin,

Zuojia Liu, Chang Li

и другие.

Phytomedicine, Год журнала: 2025, Номер 139, С. 156472 - 156472

Опубликована: Фев. 5, 2025

Язык: Английский

Процитировано

0

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets DOI

Xiaodie Gao,

Jun Ding, Junxia Xie

и другие.

Acta Pharmacologica Sinica, Год журнала: 2025, Номер unknown

Опубликована: Март 11, 2025

Язык: Английский

Процитировано

0

NEUROPROTECTIVE EFFECT OF 7,3´-DIHYDROXYFLAVONE AGAINST PACLITAXEL-INDUCED NEUROTOXICITY IN SH-SY5Y NEUROBLASTOMA CELL LINE: AN IN VITRO MODEL DOI Open Access

KEERTHANA VIJAYARAJAN,

KAVITHA RAMASAMY,

Kranthi Karunai Kadal

и другие.

Asian Journal of Pharmaceutical and Clinical Research, Год журнала: 2025, Номер unknown, С. 130 - 135

Опубликована: Март 7, 2025

Objectives: Paclitaxel (PT) induced peripheral neuropathy is associated with the neurotoxic effects of this chemotherapeutic drug. As a result, need for natural substances that can mitigate neural toxicity rising. This study investigated Neuroprotective 7,3´-dihydroxyflavone (7,3´-DHF) on PT-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Methods: The cells were exposed to 1 μM concentration PT, and protective various concentrations 7,3´-DHF evaluated. reactive oxygen species (ROS) level was measured using confocal fluorescence microscopy. proinflammatory cytokines, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) determined by enzyme-linked immunosorbent assay. Results: Treatment PT significantly reduced cell viability 19±4.8%. However, treatment PT-exposed elevated dose-dependent manner, reaching 55.34±3.8% 83.93±4.1% at 75 μg/mL 100 μg/mL, respectively. exposure ROS levels cells, but presence against toxicity. In addition, lowered increased IL-6 TNF-α exposure. Conclusion: effectively preserved under effect mediated through suppression production attenuation cytokine release, highlighting its potential as neuroprotective agent.

Язык: Английский

Процитировано

0